Sickle cell trait: what it means for your health, pregnancy, and family

The phrase "sickle cell" gets used loosely, and that creates real fear. Here is the clean line. You inherit two hemoglobin genes, one from each parent. People who inherit one sickle cell gene and one normal gene have sickle cell trait. People who inherit two sickle cell genes have sickle cell disease.

Sickle cell disease is a serious lifelong condition that causes pain crises, anemia, organ damage, and shortened lifespan. Sickle cell trait is a carrier state. The American Society of Hematology states it plainly: most individuals with sickle cell trait have an average lifespan without serious health consequences, and millions of American men, women, and children with sickle cell trait lead normal, healthy lives. The CDC and NHLBI agree that people with trait usually have none of the symptoms of sickle cell disease and lead normal lives.

If you have trait, you do not have a mild version of the disease. You have one copy of a gene, and for your own day-to-day health that is, for almost everyone, a non-event. The reason to know your status is mostly about the next generation, which we get to below. Our sickle cell condition guide covers the disease itself in depth.

Sickle cell trait is common in communities whose ancestry traces to regions where malaria was historically widespread, including much of Africa. In the United States, about 1 in 13 Black or African American babies is born with sickle cell trait.

Compare that to the disease itself: sickle cell disease occurs in about 1 out of every 365 Black or African American births, and more than 90 percent of people in the United States with sickle cell disease are non-Hispanic Black or African American. Trait is roughly an order of magnitude more common than the disease, which is exactly why the family-planning math reaches so many households.

For the vast majority of people with sickle cell trait, the answer is: very little. You are not anemic because of trait, you do not have pain crises, and you do not need ongoing treatment.

There are a small number of specific situations and conditions worth knowing about. The evidence base here was synthesized in a 2018 systematic review in the Annals of Internal Medicine that examined 24 clinical outcomes across exertion, kidney, vascular, pediatric, and surgical categories.

• Extreme exertion combined with heat and dehydration. Under extreme conditions, red cells in a person with trait can deform. The documented risk is exertional rhabdomyolysis, a breakdown of muscle tissue, which occurs most often in combination with severe heat and dehydration. The practical precautions are the same ones that protect anyone exercising hard in heat: hydrate, take rest breaks, build fitness gradually, and do not push past your conditioning.
• High altitude and low-oxygen environments. Splenic infarction, meaning death of tissue in the spleen, has been reported in people with trait at high altitude. Unpressurized aircraft and high mountains are the typical settings.
• Kidney findings. The kidney is where trait is most consistently associated with measurable effects. Some people with trait experience blood in the urine, called hematuria. The 2018 review found that trait is a risk factor for chronic kidney disease and for protein in the urine (proteinuria). These are associations across populations, not a certainty for any one person, but they are a reason to mention your trait status to your doctor and to take any blood in your urine seriously.
• Renal medullary carcinoma. This is a very rare but aggressive kidney cancer linked to sickle cell trait. A systematic review of 217 reported cases found 88 percent occurred in people with trait, and roughly half of cases were in children. The absolute risk is extremely low, but it is the reason clinicians advise that unexplained blood in the urine in a person with trait should be evaluated promptly rather than ignored.
• Blood clots. The 2018 review found evidence that trait is associated with an increased risk of venous thromboembolism, meaning clots in the veins.

None of this changes the headline: most people with trait stay healthy. It changes the footnotes. Tell your doctor you carry the trait, hydrate and pace yourself in extreme exertion, and do not dismiss blood in your urine. The American Society of Hematology is explicit that in the rare exertion-related deaths studied, the trait itself is not the cause of death; the muscle injury and its complications are, and those complications are preventable with standard precautions.

This is the part that matters for the most people. Sickle cell trait is inherited, and the genetics are straightforward.

If both parents have sickle cell trait, there is a 25 percent (1 in 4) chance that any given child will have sickle cell disease. The same coin flip, every pregnancy, gives roughly a 1 in 2 chance the child inherits trait (a carrier like the parents) and a 1 in 4 chance the child inherits neither sickle cell gene. The 1 in 4 disease risk resets with each pregnancy; it is not "used up" by an earlier healthy child.

If only one parent has trait and the other has two normal genes, no child can have sickle cell disease, though each child has a 1 in 2 chance of inheriting trait. The disease only appears when a child inherits a sickle cell gene from both parents. This is why your status alone does not tell the whole story: your reproductive partner's status is the other half of the equation.

The American College of Obstetricians and Gynecologists recommends offering hemoglobinopathy carrier screening to people who are planning a pregnancy or at the first prenatal visit if no prior results are available, using a complete blood count and hemoglobin electrophoresis (molecular genetic testing is an alternative). The logic of doing this before pregnancy, not during, is that it gives you the most options.

The sequence is simple:

1. You get tested. If you are a carrier, the next step is to have your reproductive partner tested.
2. If your partner is also a carrier, the risk of a child with a hemoglobinopathy is 1 in 4 per pregnancy.
3. If both of you carry, ACOG recommends speaking with a genetic counselor or a genetics specialist, who can walk through options for a healthy pregnancy.

Knowing this before you conceive means decisions are made calmly and with full information rather than under time pressure mid-pregnancy. If you are looking for prenatal care, our pregnancy hub and our provider directory can help you find clinicians who take this conversation seriously.

If you are wondering whether your own child has trait, you may already have the answer. All 50 states screen newborns, and the same heel-stick blood test that detects sickle cell disease also identifies sickle cell trait. Almost all newborns in the United States are screened. Ask your child's pediatrician for the newborn screening results; trait status is in that record even if no one flagged it at the time, because trait is not a disease and does not trigger treatment.

Adults have several options, and the test is a routine blood draw.

• Hemoglobin electrophoresis is the standard blood test. It measures whether your body makes hemoglobin S and how much, which distinguishes trait from disease.
• Genetic testing can confirm whether you carry one copy or two copies of the sickle cell gene.
• Where to ask: your primary care provider, an OB-GYN if you are planning a pregnancy, or many community health centers. Tell them you want hemoglobinopathy or sickle cell trait testing.

If you do not have a clinician yet, our provider directory lists practices, and our sickle cell guide explains what the results mean once you have them.